University of Oxford
Top university
6 months ago
Development of antisense oligonucleotide and base editing therapeutics for haploinsufficient neurodevelopmental disorders (MRCCoRETG2025002) University of Oxford in United Kingdom
Degree Level
PhD
Field of study
Neuroscience
Funding
Full funding availableDeadline
December 31, 2026
Country
United Kingdom
University
University of Oxford
How do I apply for this?
Sign in for free to reveal details, requirements, and source links.
Where to contact
Keywords
Neuroscience
Molecular Biology
Biology
Health Science
Developmental Biology
Pathogenesis
Neurodevelopmental Disorders
Nervous System
Neurodevelopment
Pharmacotherapy
Genomic
Biomedicine
Neurobiology
About this position
Studentship code. MRCCoRETG2025002. Neurodevelopmental disorders constitute a group of diseases in which the normal development of the nervous system is disrupted and for which treatment options are currently very limited.
Funding details
Full funding including tuition fees and living expenses is available for this position. The scholarship covers all educational costs and provides a monthly stipend.
How to apply
Please submit your application including a cover letter, CV, academic transcripts, and contact information for two references. Applications should be sent via the online portal before the deadline.
Ask ApplyKite AI
Start chatting
Can you summarize this position?
What qualifications are required for this position?
How should I prepare my application?
Professors
How do I apply for this?
Sign in for free to reveal details, requirements, and source links.